Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Viatris IncVTRS · Entity 3277 | See Remarks | March 13, 2024 | March 15, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Viatris Inc
Report date March 13, 2024 · Filed March 15, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 243,044 |
Reported balance
After 2024-03-13 transaction · row 1
1 source rowRow 1 · 2024-03-13 · Sale · Disposed 250,000 · Balance 243,044 F1: Represents the weighted average price of the reporting person's disposition of 250,000 shares of common stock in transactions ranging from $12.02 to $12.17. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of common stock sold at each separate price within the range set forth in this footnote. |
| Common StockSEC Table I · non-derivative | IndirectBy 401(k) Plan | 5,574 |
Reported balance
Holding disclosure · report date 2024-03-13 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 5,574 |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the weighted average price of the reporting person's disposition of 250,000 shares of common stock in transactions ranging from $12.02 to $12.17. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of common stock sold at each separate price within the range set forth in this footnote.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Mylan II B.V.
Report date November 16, 2020 · Filed November 18, 2020
Section 16 reporting ended · disclosed 2020-11-18. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2020-11-16 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2020-11-16 · Disposition to issuer · Disposed 119,305 · Balance 0 F1: On November 16, 2020, Mylan N.V. ("Mylan") completed the transaction pursuant to which Mylan combined with Pfizer Inc.'s ("Pfizer") Upjohn business (the "Upjohn Business") in a Reverse Morris Trust transaction (the "Combination") and Upjohn Inc. ("Upjohn") became the parent entity of the combined Upjohn Business and Mylan business and was renamed "Viatris Inc." ("Viatris"). Pursuant to the terms of the Business Combination Agreement (as amended), dated July 29, 2019, by and among Mylan, Pfizer, Upjohn and certain other affiliated entities, Upjohn and Mylan effected the Combination through a series of transactions, including that (1) Mylan merged with and into Mylan II B.V. with Mylan II B.V. surviving the merger as the legal successor of Mylan and (2) each holder of Mylan ordinary shares received one share of Viatris common stock for each Mylan ordinary share held by such holder (subject to any required withholding tax). F2: Represents ordinary shares of Mylan that were exchanged on a one-for-one basis for shares of Viatris common stock in connection with the Combination. On the effective date of the Combination, the closing price of a Mylan ordinary share was $15.85 per share. |
| Ordinary SharesSEC Table I · non-derivative | IndirectBy 401(k) Plan | 0 |
Reported balance
After 2020-11-16 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2020-11-16 · Disposition to issuer · Disposed 5,574 · Balance 0 F1: On November 16, 2020, Mylan N.V. ("Mylan") completed the transaction pursuant to which Mylan combined with Pfizer Inc.'s ("Pfizer") Upjohn business (the "Upjohn Business") in a Reverse Morris Trust transaction (the "Combination") and Upjohn Inc. ("Upjohn") became the parent entity of the combined Upjohn Business and Mylan business and was renamed "Viatris Inc." ("Viatris"). Pursuant to the terms of the Business Combination Agreement (as amended), dated July 29, 2019, by and among Mylan, Pfizer, Upjohn and certain other affiliated entities, Upjohn and Mylan effected the Combination through a series of transactions, including that (1) Mylan merged with and into Mylan II B.V. with Mylan II B.V. surviving the merger as the legal successor of Mylan and (2) each holder of Mylan ordinary shares received one share of Viatris common stock for each Mylan ordinary share held by such holder (subject to any required withholding tax). F2: Represents ordinary shares of Mylan that were exchanged on a one-for-one basis for shares of Viatris common stock in connection with the Combination. On the effective date of the Combination, the closing price of a Mylan ordinary share was $15.85 per share. |
| Employee Stock Option - Right to BuySEC Table II · derivative / convertible security · Conversion / exercise price $23.44 · Expires 2022-02-22 | Direct | 0 |
Reported balance
After 2020-11-16 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2020-11-16 · Disposition to issuer · Disposed 4,266 · Balance 0 F3: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F4: These options vested on February 22, 2015. |
| Employee Stock Option - Right to BuySEC Table II · derivative / convertible security · Conversion / exercise price $30.90 · Expires 2023-03-06 | Direct | 0 |
Reported balance
After 2020-11-16 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2020-11-16 · Disposition to issuer · Disposed 3,236 · Balance 0 F3: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F5: These options vested on March 6, 2016. |
| Employee Stock Option - Right to BuySEC Table II · derivative / convertible security · Conversion / exercise price $55.84 · Expires 2024-03-05 | Direct | 0 |
Reported balance
After 2020-11-16 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2020-11-16 · Disposition to issuer · Disposed 12,009 · Balance 0 F3: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F6: These options vested on March 5, 2017. |
| Employee Stock Option - Right to BuySEC Table II · derivative / convertible security · Conversion / exercise price $50.66 · Expires 2025-11-17 | Direct | 0 |
Reported balance
After 2020-11-16 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2020-11-16 · Disposition to issuer · Disposed 16,265 · Balance 0 F3: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F7: These options vested on March 4, 2018. |
| Employee Stock Option - Right to BuySEC Table II · derivative / convertible security · Conversion / exercise price $46.27 · Expires 2026-02-17 | Direct | 0 |
Reported balance
After 2020-11-16 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2020-11-16 · Disposition to issuer · Disposed 27,314 · Balance 0 F3: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F8: These options vested on February 17, 2019. |
| Employee Stock Option - Right to BuySEC Table II · derivative / convertible security · Conversion / exercise price $45.18 · Expires 2027-03-03 | Direct | 0 |
Reported balance
After 2020-11-16 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2020-11-16 · Disposition to issuer · Disposed 29,275 · Balance 0 F3: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F9: These options vested on March 3, 2020. |
| Employee Stock Option - Right to BuySEC Table II · derivative / convertible security · Conversion / exercise price $40.97 · Expires 2028-03-02 | Direct | 0 |
Reported balance
After 2020-11-16 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2020-11-16 · Disposition to issuer · Disposed 29,833 · Balance 0 F3: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F10: 9,945 of these options vested on March 2, 2019, 9,944 vested on March 2, 2020 and 9,944 will vest on March 2, 2021. |
| Employee Stock Option - Right to BuySEC Table II · derivative / convertible security · Conversion / exercise price $27.45 · Expires 2029-03-01 | Direct | 0 |
Reported balance
After 2020-11-16 transaction · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · 2020-11-16 · Disposition to issuer · Disposed 27,851 · Balance 0 F3: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F15: 9,284 of these options vested on March 2, 2020, 9,283 will vest on March 2, 2021 and 9,284 will vest on March 2, 2022. |
| Employee Stock Option - Right to BuySEC Table II · derivative / convertible security · Conversion / exercise price $17.48 · Expires 2030-03-02 | Direct | 0 |
Reported balance
After 2020-11-16 transaction · row 17
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 17 · 2020-11-16 · Disposition to issuer · Disposed 39,361 · Balance 0 F3: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F18: 13,121 of these options will vest on March 2, 2021 and 13,120 will vest on each of March 2, 2022 and March 2, 2023. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2020-11-16 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2020-11-16 · Disposition to issuer · Disposed 6,102 · Balance 0 F11: Represents restricted stock units ("RSUs") of Mylan that were exchanged on a one-for-one basis for RSUs of Viatris having substantially the same terms in connection with the Combination. F12: Each RSU represents the right to receive one ordinary share of Mylan. The RSUs will vest on March 2, 2021. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2020-11-16 transaction · row 14
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 14 · 2020-11-16 · Disposition to issuer · Disposed 31,087 · Balance 0 F11: Represents restricted stock units ("RSUs") of Mylan that were exchanged on a one-for-one basis for RSUs of Viatris having substantially the same terms in connection with the Combination. F16: Each RSU represents the right to receive one ordinary share of Mylan. 15,543 of the RSUs will vest on March 2, 2021 and 15,544 will vest on March 2, 2022. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2020-11-16 transaction · row 18
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 18 · 2020-11-16 · Disposition to issuer · Disposed 73,227 · Balance 0 F11: Represents restricted stock units ("RSUs") of Mylan that were exchanged on a one-for-one basis for RSUs of Viatris having substantially the same terms in connection with the Combination. F19: Each RSU represents the right to receive one ordinary share of Mylan. The RSUs will vest in three equal annual installments beginning on March 2, 2021. |
| Performance Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 30,511 |
Reported balance
After 2020-11-16 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2020-11-16 · Grant · Acquired 30,511 · Balance 30,511 F13: Each performance restricted stock unit ("PRSU") represents the right to receive one ordinary share of Mylan. The PRSUs were initially granted on March 2, 2018, subject to the attainment of previously established three-year performance goals and a vesting period. The performance goals were deemed satisfied at the target level in connection with the Combination. |
| Performance Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2020-11-16 transaction · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · 2020-11-16 · Disposition to issuer · Disposed 30,511 · Balance 0 F14: Represents PRSUs of Mylan that were exchanged on a one-for-one basis for RSUs of Viatris having substantially the same terms (other than no longer being subject to the performance-based vesting conditions) in connection with the Combination. F13: Each performance restricted stock unit ("PRSU") represents the right to receive one ordinary share of Mylan. The PRSUs were initially granted on March 2, 2018, subject to the attainment of previously established three-year performance goals and a vesting period. The performance goals were deemed satisfied at the target level in connection with the Combination. |
| Performance Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 58,288 |
Reported balance
After 2020-11-16 transaction · row 15
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 15 · 2020-11-16 · Grant · Acquired 58,288 · Balance 58,288 F17: Each PRSU represents the right to receive one ordinary share of Mylan. The PRSUs were initially granted on March 1, 2019, subject to the attainment of previously established three-year performance goals and a vesting period. The performance goals were deemed satisfied at the target level in connection with the Combination. |
| Performance Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2020-11-16 transaction · row 16
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 16 · 2020-11-16 · Disposition to issuer · Disposed 58,288 · Balance 0 F14: Represents PRSUs of Mylan that were exchanged on a one-for-one basis for RSUs of Viatris having substantially the same terms (other than no longer being subject to the performance-based vesting conditions) in connection with the Combination. F17: Each PRSU represents the right to receive one ordinary share of Mylan. The PRSUs were initially granted on March 1, 2019, subject to the attainment of previously established three-year performance goals and a vesting period. The performance goals were deemed satisfied at the target level in connection with the Combination. |
| Performance Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 91,534 |
Reported balance
After 2020-11-16 transaction · row 19
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 19 · 2020-11-16 · Grant · Acquired 91,534 · Balance 91,534 F20: Each PRSU represents the right to receive one ordinary share of Mylan. The PRSUs were initially granted on March 2, 2020, subject to the attainment of previously established three-year performance goals and a vesting period. The performance goals were deemed satisfied at the target level in connection with the Combination. |
| Performance Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2020-11-16 transaction · row 20
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 20 · 2020-11-16 · Disposition to issuer · Disposed 91,534 · Balance 0 F14: Represents PRSUs of Mylan that were exchanged on a one-for-one basis for RSUs of Viatris having substantially the same terms (other than no longer being subject to the performance-based vesting conditions) in connection with the Combination. F20: Each PRSU represents the right to receive one ordinary share of Mylan. The PRSUs were initially granted on March 2, 2020, subject to the attainment of previously established three-year performance goals and a vesting period. The performance goals were deemed satisfied at the target level in connection with the Combination. |
Filing footnotes · ownership attribution and instrument terms
F1: On November 16, 2020, Mylan N.V. ("Mylan") completed the transaction pursuant to which Mylan combined with Pfizer Inc.'s ("Pfizer") Upjohn business (the "Upjohn Business") in a Reverse Morris Trust transaction (the "Combination") and Upjohn Inc. ("Upjohn") became the parent entity of the combined Upjohn Business and Mylan business and was renamed "Viatris Inc." ("Viatris"). Pursuant to the terms of the Business Combination Agreement (as amended), dated July 29, 2019, by and among Mylan, Pfizer, Upjohn and certain other affiliated entities, Upjohn and Mylan effected the Combination through a series of transactions, including that (1) Mylan merged with and into Mylan II B.V. with Mylan II B.V. surviving the merger as the legal successor of Mylan and (2) each holder of Mylan ordinary shares received one share of Viatris common stock for each Mylan ordinary share held by such holder (subject to any required withholding tax).
F2: Represents ordinary shares of Mylan that were exchanged on a one-for-one basis for shares of Viatris common stock in connection with the Combination. On the effective date of the Combination, the closing price of a Mylan ordinary share was $15.85 per share.
F3: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination.
F4: These options vested on February 22, 2015.
F5: These options vested on March 6, 2016.
F6: These options vested on March 5, 2017.
F7: These options vested on March 4, 2018.
F8: These options vested on February 17, 2019.
F9: These options vested on March 3, 2020.
F10: 9,945 of these options vested on March 2, 2019, 9,944 vested on March 2, 2020 and 9,944 will vest on March 2, 2021.
F11: Represents restricted stock units ("RSUs") of Mylan that were exchanged on a one-for-one basis for RSUs of Viatris having substantially the same terms in connection with the Combination.
F12: Each RSU represents the right to receive one ordinary share of Mylan. The RSUs will vest on March 2, 2021.
F13: Each performance restricted stock unit ("PRSU") represents the right to receive one ordinary share of Mylan. The PRSUs were initially granted on March 2, 2018, subject to the attainment of previously established three-year performance goals and a vesting period. The performance goals were deemed satisfied at the target level in connection with the Combination.
F14: Represents PRSUs of Mylan that were exchanged on a one-for-one basis for RSUs of Viatris having substantially the same terms (other than no longer being subject to the performance-based vesting conditions) in connection with the Combination.
F15: 9,284 of these options vested on March 2, 2020, 9,283 will vest on March 2, 2021 and 9,284 will vest on March 2, 2022.
F16: Each RSU represents the right to receive one ordinary share of Mylan. 15,543 of the RSUs will vest on March 2, 2021 and 15,544 will vest on March 2, 2022.
F17: Each PRSU represents the right to receive one ordinary share of Mylan. The PRSUs were initially granted on March 1, 2019, subject to the attainment of previously established three-year performance goals and a vesting period. The performance goals were deemed satisfied at the target level in connection with the Combination.
F18: 13,121 of these options will vest on March 2, 2021 and 13,120 will vest on each of March 2, 2022 and March 2, 2023.
F19: Each RSU represents the right to receive one ordinary share of Mylan. The RSUs will vest in three equal annual installments beginning on March 2, 2021.
F20: Each PRSU represents the right to receive one ordinary share of Mylan. The PRSUs were initially granted on March 2, 2020, subject to the attainment of previously established three-year performance goals and a vesting period. The performance goals were deemed satisfied at the target level in connection with the Combination.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 02, 2022 Filed Mar 4, 2022 20:12 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionCommon Stock | 714 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-009564 · doc4.xml · nonDerivative · entry 9 Mauro Anthony · CIK 0001534275 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 235,602 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · shares: Fractional shares have been rounded up in connection with the settlement described in footnote 12 pursuant to the terms of the RSU award agreement under the Viatris Inc. 2020 Stock Incentive Plan. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 20:12 UTC | Viatris Inc VTRS · Entity 3277 | Tax withholdingCommon Stock | 12,983 | $10.48 | $136,061.84 |
DisclosureSEC source: 0000899243-22-009564 · doc4.xml · nonDerivative · entry 8 Mauro Anthony · CIK 0001534275 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 234,888 F4 · shares: Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of a portion of the RSUs granted on March 2, 2021. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 20:12 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionCommon Stock | 29,858 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-009564 · doc4.xml · nonDerivative · entry 7 Mauro Anthony · CIK 0001534275 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 247,871 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 20:12 UTC | Viatris Inc VTRS · Entity 3277 | Tax withholdingCommon Stock | 10,614 | $10.48 | $111,234.72 |
DisclosureSEC source: 0000899243-22-009564 · doc4.xml · nonDerivative · entry 6 Mauro Anthony · CIK 0001534275 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 218,013 F3 · shares: Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of a portion of the RSUs granted on March 2, 2020. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 20:12 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionCommon Stock | 24,409 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-009564 · doc4.xml · nonDerivative · entry 5 Mauro Anthony · CIK 0001534275 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 228,627 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 20:12 UTC | Viatris Inc VTRS · Entity 3277 | Tax withholdingCommon Stock | 25,344 | $10.48 | $265,605.12 |
DisclosureSEC source: 0000899243-22-009564 · doc4.xml · nonDerivative · entry 4 Mauro Anthony · CIK 0001534275 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 204,218 F2 · shares: Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of the RSUs granted on March 1, 2019. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 20:12 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionCommon Stock | 58,288 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-009564 · doc4.xml · nonDerivative · entry 3 Mauro Anthony · CIK 0001534275 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 229,562 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 20:12 UTC | Viatris Inc VTRS · Entity 3277 | Tax withholdingCommon Stock | 6,820 | $10.48 | $71,473.60 |
DisclosureSEC source: 0000899243-22-009564 · doc4.xml · nonDerivative · entry 2 Mauro Anthony · CIK 0001534275 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 171,274 F1 · shares: Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of a portion of the restricted stock units (RSUs) granted on March 1, 2019. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 20:12 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionCommon Stock | 15,544 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-009564 · doc4.xml · nonDerivative · entry 1 Mauro Anthony · CIK 0001534275 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 178,094 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 21, 2021 Filed Dec 23, 2021 18:01 UTC | Viatris Inc VTRS · Entity 3277 | GrantDividend Equivalent Units · Derivative | 768.3636 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-049642 · doc4.xml · derivative · entry 1 Mauro Anthony · CIK 0001534275 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,140.6791 Underlying: Common Stock · 768.3636 shares Expires not disclosed F1 · derivative.exercise_price: Represents dividend equivalent units ("DEUs") that accrued with respect to restricted stock units ("RSUs") previously granted on March 2, 2021 and vest on the same schedule as the underlying RSUs. F1 · derivative.exercise_date: Represents dividend equivalent units ("DEUs") that accrued with respect to restricted stock units ("RSUs") previously granted on March 2, 2021 and vest on the same schedule as the underlying RSUs. F1 · derivative.expiration_date: Represents dividend equivalent units ("DEUs") that accrued with respect to restricted stock units ("RSUs") previously granted on March 2, 2021 and vest on the same schedule as the underlying RSUs. Read SEC document |
| September 22, 2021 Filed Sep 24, 2021 18:00 UTC | Viatris Inc VTRS · Entity 3277 | GrantDividend Equivalent Units · Derivative | 724.9344 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-037651 · doc4.xml · derivative · entry 1 Mauro Anthony · CIK 0001534275 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,372.3155 Underlying: Common Stock · 724.9344 shares Expires not disclosed F1 · derivative.exercise_price: Represents dividend equivalent units ("DEUs") that accrued with respect to restricted stock units ("RSUs") previously granted on March 2, 2021 and vest on the same schedule as the underlying RSUs. F1 · derivative.exercise_date: Represents dividend equivalent units ("DEUs") that accrued with respect to restricted stock units ("RSUs") previously granted on March 2, 2021 and vest on the same schedule as the underlying RSUs. F1 · derivative.expiration_date: Represents dividend equivalent units ("DEUs") that accrued with respect to restricted stock units ("RSUs") previously granted on March 2, 2021 and vest on the same schedule as the underlying RSUs. Read SEC document |
| June 21, 2021 Filed Jun 23, 2021 20:47 UTC | Viatris Inc VTRS · Entity 3277 | GrantDividend Equivalent Units · Derivative | 647.3811 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-025623 · doc4.xml · derivative · entry 1 Mauro Anthony · CIK 0001534275 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 647.3811 Underlying: Common Stock · 647.3811 shares Expires not disclosed F1 · derivative.exercise_price: Represents dividend equivalent units ("DEUs") that accrued with respect to restricted stock units ("RSUs") previously granted on March 2, 2021 and vest on the same schedule as the underlying RSUs. F1 · derivative.exercise_date: Represents dividend equivalent units ("DEUs") that accrued with respect to restricted stock units ("RSUs") previously granted on March 2, 2021 and vest on the same schedule as the underlying RSUs. F1 · derivative.expiration_date: Represents dividend equivalent units ("DEUs") that accrued with respect to restricted stock units ("RSUs") previously granted on March 2, 2021 and vest on the same schedule as the underlying RSUs. Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 18:35 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionRestricted Stock Units · Derivative | 24,409 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-009932 · doc4.xml · derivative · entry 14 Mauro Anthony · CIK 0001534275 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,818 Underlying: Common Stock · 24,409 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: Each RSU represents the right to receive one share of common stock of Viatris. 24,409 of the RSUs granted on March 2, 2020 vested on March 2, 2021, and 24,409 will vest on each of March 2, 2022 and March 2, 2023. F9 · derivative.expiration_date: Each RSU represents the right to receive one share of common stock of Viatris. 24,409 of the RSUs granted on March 2, 2020 vested on March 2, 2021, and 24,409 will vest on each of March 2, 2022 and March 2, 2023. Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 18:35 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionRestricted Stock Units · Derivative | 15,543 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-009932 · doc4.xml · derivative · entry 13 Mauro Anthony · CIK 0001534275 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,544 Underlying: Common Stock · 15,543 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: Each RSU represents the right to receive one share of common stock of Viatris. 15,544 of the RSUs granted on March 1, 2019 vested on March 2, 2020, 15,543 vested on March 2, 2021, and 15,544 will vest on March 2, 2022 F8 · derivative.expiration_date: Each RSU represents the right to receive one share of common stock of Viatris. 15,544 of the RSUs granted on March 1, 2019 vested on March 2, 2020, 15,543 vested on March 2, 2021, and 15,544 will vest on March 2, 2022 Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 18:35 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionRestricted Stock Units · Derivative | 30,511 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-009932 · doc4.xml · derivative · entry 12 Mauro Anthony · CIK 0001534275 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,511 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: Each RSU represents the right to receive one share of common stock of Viatris. The RSUs granted on March 2, 2018 vested in full on March 2, 2021. F7 · derivative.expiration_date: Each RSU represents the right to receive one share of common stock of Viatris. The RSUs granted on March 2, 2018 vested in full on March 2, 2021. Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 18:35 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionRestricted Stock Units · Derivative | 6,102 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-009932 · doc4.xml · derivative · entry 11 Mauro Anthony · CIK 0001534275 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,102 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Each RSU represents the right to receive one share of common stock of Viatris. 6,103 of the RSUs granted on March 2, 2018 vested on March 2, 2019 and 6,102 vested on each of March 2, 2020, and March 2, 2021. F6 · derivative.expiration_date: Each RSU represents the right to receive one share of common stock of Viatris. 6,103 of the RSUs granted on March 2, 2018 vested on March 2, 2019 and 6,102 vested on each of March 2, 2020, and March 2, 2021. Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 18:35 UTC | Viatris Inc VTRS · Entity 3277 | GrantRestricted Stock Units · Derivative | 89,574 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-009932 · doc4.xml · derivative · entry 10 Mauro Anthony · CIK 0001534275 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,574 Underlying: Common Stock · 89,574 shares Expires not disclosed F5 · derivative.exercise_date: Each RSU represents the right to receive one share of common stock of Viatris Inc. ("Viatris"). The RSUs vest in three equal annual installments beginning on March 2, 2022. F5 · derivative.expiration_date: Each RSU represents the right to receive one share of common stock of Viatris Inc. ("Viatris"). The RSUs vest in three equal annual installments beginning on March 2, 2022. Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 18:35 UTC | Viatris Inc VTRS · Entity 3277 | Tax withholdingCommon Stock | 10,614 | $14.29 | $151,674.06 |
DisclosureSEC source: 0000899243-21-009932 · doc4.xml · nonDerivative · entry 8 Mauro Anthony · CIK 0001534275 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,550 F4 · shares: Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of a portion of the RSUs granted on March 2, 2020 Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 18:35 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionCommon Stock | 24,409 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-009932 · doc4.xml · nonDerivative · entry 7 Mauro Anthony · CIK 0001534275 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 173,164 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 18:35 UTC | Viatris Inc VTRS · Entity 3277 | Tax withholdingCommon Stock | 6,759 | $14.29 | $96,586.11 |
DisclosureSEC source: 0000899243-21-009932 · doc4.xml · nonDerivative · entry 6 Mauro Anthony · CIK 0001534275 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148,755 F3 · shares: Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of a portion of the RSUs granted on March 1, 2019. Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 18:35 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionCommon Stock | 15,543 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-009932 · doc4.xml · nonDerivative · entry 5 Mauro Anthony · CIK 0001534275 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,514 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 18:35 UTC | Viatris Inc VTRS · Entity 3277 | Tax withholdingCommon Stock | 13,267 | $14.29 | $189,585.43 |
DisclosureSEC source: 0000899243-21-009932 · doc4.xml · nonDerivative · entry 4 Mauro Anthony · CIK 0001534275 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,971 F2 · shares: Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of the RSUs granted on March 2, 2018. Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 18:35 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionCommon Stock | 30,511 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-009932 · doc4.xml · nonDerivative · entry 3 Mauro Anthony · CIK 0001534275 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 153,238 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 18:35 UTC | Viatris Inc VTRS · Entity 3277 | Tax withholdingCommon Stock | 2,680 | $14.29 | $38,297.20 |
DisclosureSEC source: 0000899243-21-009932 · doc4.xml · nonDerivative · entry 2 Mauro Anthony · CIK 0001534275 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,727 F1 · shares: Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of a portion of the restricted stock units (RSUs) granted on March 2, 2018. Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 18:35 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionCommon Stock | 6,102 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-009932 · doc4.xml · nonDerivative · entry 1 Mauro Anthony · CIK 0001534275 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,407 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 19:20 UTC | Mylan II B.V. MYL · Entity 16217 | Disposition to issuerPerformance Restricted Stock Units · Derivative | 91,534 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0000899243-20-031511 · doc4.xml · derivative · entry 20 Mauro Anthony · CIK 0001534275 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 91,534 shares Expires not disclosed F14 · security: Represents PRSUs of Mylan that were exchanged on a one-for-one basis for RSUs of Viatris having substantially the same terms (other than no longer being subject to the performance-based vesting conditions) in connection with the Combination. F14 · price: Represents PRSUs of Mylan that were exchanged on a one-for-one basis for RSUs of Viatris having substantially the same terms (other than no longer being subject to the performance-based vesting conditions) in connection with the Combination. F20 · derivative.exercise_date: Each PRSU represents the right to receive one ordinary share of Mylan. The PRSUs were initially granted on March 2, 2020, subject to the attainment of previously established three-year performance goals and a vesting period. The performance goals were deemed satisfied at the target level in connection with the Combination. F20 · derivative.expiration_date: Each PRSU represents the right to receive one ordinary share of Mylan. The PRSUs were initially granted on March 2, 2020, subject to the attainment of previously established three-year performance goals and a vesting period. The performance goals were deemed satisfied at the target level in connection with the Combination. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 19:20 UTC | Mylan II B.V. MYL · Entity 16217 | GrantPerformance Restricted Stock Units · Derivative | 91,534 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-031511 · doc4.xml · derivative · entry 19 Mauro Anthony · CIK 0001534275 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,534 Underlying: Ordinary Shares · 91,534 shares Expires not disclosed F20 · derivative.exercise_date: Each PRSU represents the right to receive one ordinary share of Mylan. The PRSUs were initially granted on March 2, 2020, subject to the attainment of previously established three-year performance goals and a vesting period. The performance goals were deemed satisfied at the target level in connection with the Combination. F20 · derivative.expiration_date: Each PRSU represents the right to receive one ordinary share of Mylan. The PRSUs were initially granted on March 2, 2020, subject to the attainment of previously established three-year performance goals and a vesting period. The performance goals were deemed satisfied at the target level in connection with the Combination. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 19:20 UTC | Mylan II B.V. MYL · Entity 16217 | Disposition to issuerRestricted Stock Units · Derivative | 73,227 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0000899243-20-031511 · doc4.xml · derivative · entry 18 Mauro Anthony · CIK 0001534275 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 73,227 shares Expires not disclosed F11 · security: Represents restricted stock units ("RSUs") of Mylan that were exchanged on a one-for-one basis for RSUs of Viatris having substantially the same terms in connection with the Combination. F11 · price: Represents restricted stock units ("RSUs") of Mylan that were exchanged on a one-for-one basis for RSUs of Viatris having substantially the same terms in connection with the Combination. F19 · derivative.exercise_date: Each RSU represents the right to receive one ordinary share of Mylan. The RSUs will vest in three equal annual installments beginning on March 2, 2021. F19 · derivative.expiration_date: Each RSU represents the right to receive one ordinary share of Mylan. The RSUs will vest in three equal annual installments beginning on March 2, 2021. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 19:20 UTC | Mylan II B.V. MYL · Entity 16217 | Disposition to issuerEmployee Stock Option - Right to Buy · Derivative | 39,361 | Not disclosed Strike: $17.48 | Not disclosed |
DisclosureSEC source: 0000899243-20-031511 · doc4.xml · derivative · entry 17 Mauro Anthony · CIK 0001534275 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 39,361 shares Expires 2030-03-02 F3 · security: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F3 · price: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F18 · derivative.exercise_date: 13,121 of these options will vest on March 2, 2021 and 13,120 will vest on each of March 2, 2022 and March 2, 2023. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 19:20 UTC | Mylan II B.V. MYL · Entity 16217 | Disposition to issuerPerformance Restricted Stock Units · Derivative | 58,288 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0000899243-20-031511 · doc4.xml · derivative · entry 16 Mauro Anthony · CIK 0001534275 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 58,288 shares Expires not disclosed F14 · security: Represents PRSUs of Mylan that were exchanged on a one-for-one basis for RSUs of Viatris having substantially the same terms (other than no longer being subject to the performance-based vesting conditions) in connection with the Combination. F14 · price: Represents PRSUs of Mylan that were exchanged on a one-for-one basis for RSUs of Viatris having substantially the same terms (other than no longer being subject to the performance-based vesting conditions) in connection with the Combination. F17 · derivative.exercise_date: Each PRSU represents the right to receive one ordinary share of Mylan. The PRSUs were initially granted on March 1, 2019, subject to the attainment of previously established three-year performance goals and a vesting period. The performance goals were deemed satisfied at the target level in connection with the Combination. F17 · derivative.expiration_date: Each PRSU represents the right to receive one ordinary share of Mylan. The PRSUs were initially granted on March 1, 2019, subject to the attainment of previously established three-year performance goals and a vesting period. The performance goals were deemed satisfied at the target level in connection with the Combination. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 19:20 UTC | Mylan II B.V. MYL · Entity 16217 | GrantPerformance Restricted Stock Units · Derivative | 58,288 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-031511 · doc4.xml · derivative · entry 15 Mauro Anthony · CIK 0001534275 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,288 Underlying: Ordinary Shares · 58,288 shares Expires not disclosed F17 · derivative.exercise_date: Each PRSU represents the right to receive one ordinary share of Mylan. The PRSUs were initially granted on March 1, 2019, subject to the attainment of previously established three-year performance goals and a vesting period. The performance goals were deemed satisfied at the target level in connection with the Combination. F17 · derivative.expiration_date: Each PRSU represents the right to receive one ordinary share of Mylan. The PRSUs were initially granted on March 1, 2019, subject to the attainment of previously established three-year performance goals and a vesting period. The performance goals were deemed satisfied at the target level in connection with the Combination. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 19:20 UTC | Mylan II B.V. MYL · Entity 16217 | Disposition to issuerRestricted Stock Units · Derivative | 31,087 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0000899243-20-031511 · doc4.xml · derivative · entry 14 Mauro Anthony · CIK 0001534275 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 31,087 shares Expires not disclosed F11 · security: Represents restricted stock units ("RSUs") of Mylan that were exchanged on a one-for-one basis for RSUs of Viatris having substantially the same terms in connection with the Combination. F11 · price: Represents restricted stock units ("RSUs") of Mylan that were exchanged on a one-for-one basis for RSUs of Viatris having substantially the same terms in connection with the Combination. F16 · derivative.exercise_date: Each RSU represents the right to receive one ordinary share of Mylan. 15,543 of the RSUs will vest on March 2, 2021 and 15,544 will vest on March 2, 2022. F16 · derivative.expiration_date: Each RSU represents the right to receive one ordinary share of Mylan. 15,543 of the RSUs will vest on March 2, 2021 and 15,544 will vest on March 2, 2022. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 19:20 UTC | Mylan II B.V. MYL · Entity 16217 | Disposition to issuerEmployee Stock Option - Right to Buy · Derivative | 27,851 | Not disclosed Strike: $27.45 | Not disclosed |
DisclosureSEC source: 0000899243-20-031511 · doc4.xml · derivative · entry 13 Mauro Anthony · CIK 0001534275 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 27,851 shares Expires 2029-03-01 F3 · security: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F3 · price: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F15 · derivative.exercise_date: 9,284 of these options vested on March 2, 2020, 9,283 will vest on March 2, 2021 and 9,284 will vest on March 2, 2022. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 19:20 UTC | Mylan II B.V. MYL · Entity 16217 | Disposition to issuerPerformance Restricted Stock Units · Derivative | 30,511 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0000899243-20-031511 · doc4.xml · derivative · entry 12 Mauro Anthony · CIK 0001534275 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 30,511 shares Expires not disclosed F14 · security: Represents PRSUs of Mylan that were exchanged on a one-for-one basis for RSUs of Viatris having substantially the same terms (other than no longer being subject to the performance-based vesting conditions) in connection with the Combination. F14 · price: Represents PRSUs of Mylan that were exchanged on a one-for-one basis for RSUs of Viatris having substantially the same terms (other than no longer being subject to the performance-based vesting conditions) in connection with the Combination. F13 · derivative.exercise_date: Each performance restricted stock unit ("PRSU") represents the right to receive one ordinary share of Mylan. The PRSUs were initially granted on March 2, 2018, subject to the attainment of previously established three-year performance goals and a vesting period. The performance goals were deemed satisfied at the target level in connection with the Combination. F13 · derivative.expiration_date: Each performance restricted stock unit ("PRSU") represents the right to receive one ordinary share of Mylan. The PRSUs were initially granted on March 2, 2018, subject to the attainment of previously established three-year performance goals and a vesting period. The performance goals were deemed satisfied at the target level in connection with the Combination. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 19:20 UTC | Mylan II B.V. MYL · Entity 16217 | GrantPerformance Restricted Stock Units · Derivative | 30,511 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-031511 · doc4.xml · derivative · entry 11 Mauro Anthony · CIK 0001534275 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,511 Underlying: Ordinary Shares · 30,511 shares Expires not disclosed F13 · derivative.exercise_date: Each performance restricted stock unit ("PRSU") represents the right to receive one ordinary share of Mylan. The PRSUs were initially granted on March 2, 2018, subject to the attainment of previously established three-year performance goals and a vesting period. The performance goals were deemed satisfied at the target level in connection with the Combination. F13 · derivative.expiration_date: Each performance restricted stock unit ("PRSU") represents the right to receive one ordinary share of Mylan. The PRSUs were initially granted on March 2, 2018, subject to the attainment of previously established three-year performance goals and a vesting period. The performance goals were deemed satisfied at the target level in connection with the Combination. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 19:20 UTC | Mylan II B.V. MYL · Entity 16217 | Disposition to issuerRestricted Stock Units · Derivative | 6,102 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0000899243-20-031511 · doc4.xml · derivative · entry 10 Mauro Anthony · CIK 0001534275 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 6,102 shares Expires not disclosed F11 · security: Represents restricted stock units ("RSUs") of Mylan that were exchanged on a one-for-one basis for RSUs of Viatris having substantially the same terms in connection with the Combination. F11 · price: Represents restricted stock units ("RSUs") of Mylan that were exchanged on a one-for-one basis for RSUs of Viatris having substantially the same terms in connection with the Combination. F12 · derivative.exercise_date: Each RSU represents the right to receive one ordinary share of Mylan. The RSUs will vest on March 2, 2021. F12 · derivative.expiration_date: Each RSU represents the right to receive one ordinary share of Mylan. The RSUs will vest on March 2, 2021. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 19:20 UTC | Mylan II B.V. MYL · Entity 16217 | Disposition to issuerEmployee Stock Option - Right to Buy · Derivative | 29,833 | Not disclosed Strike: $40.97 | Not disclosed |
DisclosureSEC source: 0000899243-20-031511 · doc4.xml · derivative · entry 9 Mauro Anthony · CIK 0001534275 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 29,833 shares Expires 2028-03-02 F3 · security: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F3 · price: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F10 · derivative.exercise_date: 9,945 of these options vested on March 2, 2019, 9,944 vested on March 2, 2020 and 9,944 will vest on March 2, 2021. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 19:20 UTC | Mylan II B.V. MYL · Entity 16217 | Disposition to issuerEmployee Stock Option - Right to Buy · Derivative | 29,275 | Not disclosed Strike: $45.18 | Not disclosed |
DisclosureSEC source: 0000899243-20-031511 · doc4.xml · derivative · entry 8 Mauro Anthony · CIK 0001534275 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 29,275 shares Expires 2027-03-03 F3 · security: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F3 · price: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F9 · derivative.exercise_date: These options vested on March 3, 2020. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 19:20 UTC | Mylan II B.V. MYL · Entity 16217 | Disposition to issuerEmployee Stock Option - Right to Buy · Derivative | 27,314 | Not disclosed Strike: $46.27 | Not disclosed |
DisclosureSEC source: 0000899243-20-031511 · doc4.xml · derivative · entry 7 Mauro Anthony · CIK 0001534275 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 27,314 shares Expires 2026-02-17 F3 · security: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F3 · price: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F8 · derivative.exercise_date: These options vested on February 17, 2019. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 19:20 UTC | Mylan II B.V. MYL · Entity 16217 | Disposition to issuerEmployee Stock Option - Right to Buy · Derivative | 16,265 | Not disclosed Strike: $50.66 | Not disclosed |
DisclosureSEC source: 0000899243-20-031511 · doc4.xml · derivative · entry 6 Mauro Anthony · CIK 0001534275 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 16,265 shares Expires 2025-11-17 F3 · security: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F3 · price: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F7 · derivative.exercise_date: These options vested on March 4, 2018. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 19:20 UTC | Mylan II B.V. MYL · Entity 16217 | Disposition to issuerEmployee Stock Option - Right to Buy · Derivative | 12,009 | Not disclosed Strike: $55.84 | Not disclosed |
DisclosureSEC source: 0000899243-20-031511 · doc4.xml · derivative · entry 5 Mauro Anthony · CIK 0001534275 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 12,009 shares Expires 2024-03-05 F3 · security: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F3 · price: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F6 · derivative.exercise_date: These options vested on March 5, 2017. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 19:20 UTC | Mylan II B.V. MYL · Entity 16217 | Disposition to issuerEmployee Stock Option - Right to Buy · Derivative | 3,236 | Not disclosed Strike: $30.90 | Not disclosed |
DisclosureSEC source: 0000899243-20-031511 · doc4.xml · derivative · entry 4 Mauro Anthony · CIK 0001534275 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 3,236 shares Expires 2023-03-06 F3 · security: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F3 · price: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F5 · derivative.exercise_date: These options vested on March 6, 2016. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 19:20 UTC | Mylan II B.V. MYL · Entity 16217 | Disposition to issuerEmployee Stock Option - Right to Buy · Derivative | 4,266 | Not disclosed Strike: $23.44 | Not disclosed |
DisclosureSEC source: 0000899243-20-031511 · doc4.xml · derivative · entry 3 Mauro Anthony · CIK 0001534275 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 4,266 shares Expires 2022-02-22 F3 · security: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F3 · price: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F4 · derivative.exercise_date: These options vested on February 22, 2015. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 19:20 UTC | Mylan II B.V. MYL · Entity 16217 | Disposition to issuerOrdinary Shares | 5,574 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-20-031511 · doc4.xml · nonDerivative · entry 2 Mauro Anthony · CIK 0001534275 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By 401(k) Plan Disclosed balance after: 0 F1 · security: On November 16, 2020, Mylan N.V. ("Mylan") completed the transaction pursuant to which Mylan combined with Pfizer Inc.'s ("Pfizer") Upjohn business (the "Upjohn Business") in a Reverse Morris Trust transaction (the "Combination") and Upjohn Inc. ("Upjohn") became the parent entity of the combined Upjohn Business and Mylan business and was renamed "Viatris Inc." ("Viatris"). Pursuant to the terms of the Business Combination Agreement (as amended), dated July 29, 2019, by and among Mylan, Pfizer, Upjohn and certain other affiliated entities, Upjohn and Mylan effected the Combination through a series of transactions, including that (1) Mylan merged with and into Mylan II B.V. with Mylan II B.V. surviving the merger as the legal successor of Mylan and (2) each holder of Mylan ordinary shares received one share of Viatris common stock for each Mylan ordinary share held by such holder (subject to any required withholding tax). F2 · price: Represents ordinary shares of Mylan that were exchanged on a one-for-one basis for shares of Viatris common stock in connection with the Combination. On the effective date of the Combination, the closing price of a Mylan ordinary share was $15.85 per share. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 19:20 UTC | Mylan II B.V. MYL · Entity 16217 | Disposition to issuerOrdinary Shares | 119,305 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-20-031511 · doc4.xml · nonDerivative · entry 1 Mauro Anthony · CIK 0001534275 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: On November 16, 2020, Mylan N.V. ("Mylan") completed the transaction pursuant to which Mylan combined with Pfizer Inc.'s ("Pfizer") Upjohn business (the "Upjohn Business") in a Reverse Morris Trust transaction (the "Combination") and Upjohn Inc. ("Upjohn") became the parent entity of the combined Upjohn Business and Mylan business and was renamed "Viatris Inc." ("Viatris"). Pursuant to the terms of the Business Combination Agreement (as amended), dated July 29, 2019, by and among Mylan, Pfizer, Upjohn and certain other affiliated entities, Upjohn and Mylan effected the Combination through a series of transactions, including that (1) Mylan merged with and into Mylan II B.V. with Mylan II B.V. surviving the merger as the legal successor of Mylan and (2) each holder of Mylan ordinary shares received one share of Viatris common stock for each Mylan ordinary share held by such holder (subject to any required withholding tax). F2 · price: Represents ordinary shares of Mylan that were exchanged on a one-for-one basis for shares of Viatris common stock in connection with the Combination. On the effective date of the Combination, the closing price of a Mylan ordinary share was $15.85 per share. Read SEC document |
| March 03, 2020 Filed Mar 4, 2020 18:31 UTC | Mylan II B.V. MYL · Entity 16217 | Exercise / conversionPerformance Restricted Stock Units · Derivative | 13,834 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-007016 · doc4.xml · derivative · entry 16 Mauro Anthony · CIK 0001534275 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 13,834 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_date: Each PRSU represents the right to receive one ordinary share of Mylan N.V. The PRSUs were initially granted on March 3, 2017, subject to the attainment of previously established three-year performance goals and a vesting period. The PRSUs fully vested on March 3, 2020. F10 · derivative.expiration_date: Each PRSU represents the right to receive one ordinary share of Mylan N.V. The PRSUs were initially granted on March 3, 2017, subject to the attainment of previously established three-year performance goals and a vesting period. The PRSUs fully vested on March 3, 2020. Read SEC document |
| March 03, 2020 Filed Mar 4, 2020 18:31 UTC | Mylan II B.V. MYL · Entity 16217 | GrantPerformance Restricted Stock Units · Derivative | 13,834 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-007016 · doc4.xml · derivative · entry 15 Mauro Anthony · CIK 0001534275 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,834 Underlying: Ordinary Shares · 13,834 shares Expires not disclosed F10 · derivative.exercise_date: Each PRSU represents the right to receive one ordinary share of Mylan N.V. The PRSUs were initially granted on March 3, 2017, subject to the attainment of previously established three-year performance goals and a vesting period. The PRSUs fully vested on March 3, 2020. F10 · derivative.expiration_date: Each PRSU represents the right to receive one ordinary share of Mylan N.V. The PRSUs were initially granted on March 3, 2017, subject to the attainment of previously established three-year performance goals and a vesting period. The PRSUs fully vested on March 3, 2020. Read SEC document |
| March 03, 2020 Filed Mar 4, 2020 18:31 UTC | Mylan II B.V. MYL · Entity 16217 | Exercise / conversionRestricted Stock Units · Derivative | 5,533 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-007016 · doc4.xml · derivative · entry 14 Mauro Anthony · CIK 0001534275 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 5,533 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: Each RSU represents the right to receive one ordinary share of Mylan N.V. 5,534 of the RSUs granted on March 3, 2017 vested on each of March 3, 2018 and March 3, 2019, and 5,533 vested on March 3, 2020. F9 · derivative.expiration_date: Each RSU represents the right to receive one ordinary share of Mylan N.V. 5,534 of the RSUs granted on March 3, 2017 vested on each of March 3, 2018 and March 3, 2019, and 5,533 vested on March 3, 2020. Read SEC document |
| March 03, 2020 Filed Mar 4, 2020 18:31 UTC | Mylan II B.V. MYL · Entity 16217 | Tax withholdingOrdinary Shares | 6,016 | $16.29 | $98,000.64 |
DisclosureSEC source: 0000899243-20-007016 · doc4.xml · nonDerivative · entry 8 Mauro Anthony · CIK 0001534275 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,305 F4 · shares: Represents withholding of ordinary shares for the tax liability associated with the vesting and settlement of a portion of the performance restricted stock units (PRSUs) granted on March 3, 2017. Read SEC document |
| March 03, 2020 Filed Mar 4, 2020 18:31 UTC | Mylan II B.V. MYL · Entity 16217 | Exercise / conversionOrdinary Shares | 13,834 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-007016 · doc4.xml · nonDerivative · entry 7 Mauro Anthony · CIK 0001534275 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,321 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.